SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Gronowitz Simon)
 

Search: WFRF:(Gronowitz Simon) > Increased Prolifera...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003059naa a2200325 4500
001oai:DiVA.org:uu-215297
003SwePub
008140113s2013 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2152972 URI
024a https://doi.org/10.1158/1055-9965.EPI-13-01932 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Nisman, Benjamin4 aut
2451 0a Increased Proliferative Background in Healthy Women with BRCA1/2 Haploinsufficiency Is Associated with High Risk for Breast Cancer
264 1c 2013
338 a print2 rdacarrier
520 a Previous studies indicated that BRCA haploinsufficiency was associated with activation of the EGF receptor (EGFR) signaling pathway and increased proliferative activity in mammary epithelial cells of healthy women. We hypothesized that these processes might be reflected in the expression of serologic soluble EGFR (sEGFR) and thymidine kinase 1 (TK1) activity, which signal the initial and final steps of the proliferative pathway, respectively. We found that healthy carriers of BRCA1/2 mutations (n = 80) showed a significantly higher TK1 activity than age-matched controls (P = 0.0003), and TK1 activity was similar in women with BRCA1 and BRCA2 mutations (P = 0.74). The sEGFR concentration was significantly higher in women with BRCA1 than in controls and BRCA2 mutation (P = 0.013 and 0.002, respectively). During follow-up, four of 80 BRCA1/2 mutation carriers developed breast cancer. These women showed a significantly higher TK1 activity and somewhat higher sEGFR concentrations than the other 76 BRCA1/2 carriers (P = 0.04 and 0.09, respectively). All tumors were negative for ovarian hormone receptors, but showed a high EGFR expression. This study was limited by the short-term follow-up (mean, 27 months; range, 5-45), which resulted in a small sample size. Women with BRCA1 and BRCA2 mutations that had undergone risk-reducing bilateral salpingo-oophorectomy (BSO) showed significantly lower sEGFR compared with those without surgery (P = 0.007 and 0.038, respectively). Larger, prospective studies are warranted to investigate whether TK1 and sEGFR measurements may be useful for identifying healthy BRCA1/2 carriers with high risk of developing breast cancer; moreover, sEGFR measurements may serve as effective tools for assessing risk before and after BSO.
700a Kadouri, Luna4 aut
700a Allweis, Tanir4 aut
700a Maly, Bella4 aut
700a Hamburger, Tamar4 aut
700a Gronowitz, Simonu Uppsala universitet,Klinisk virologi4 aut0 (Swepub:uu)simongro
700a Peretz, Tamar4 aut
710a Uppsala universitetb Klinisk virologi4 org
773t Cancer Epidemiology, Biomarkers and Preventiong 22:11, s. 2110-2115q 22:11<2110-2115x 1055-9965x 1538-7755
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-215297
8564 8u https://doi.org/10.1158/1055-9965.EPI-13-0193

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view